Reply to Wen-Wei Sung's Letter to the Editor re: Wei Shen Tan, Ian M. McElree, Facundo Davaro, et al. Sequential Intravesical Gemcitabine and Docetaxel Is an Alternative to Bacillus Calmette-Guérin for the Treatment of Intermediate-risk Non-muscle-invasive Bladder Cancer. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.06.011

Affiliations

• ¹ Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
• ² Department of Urology, University of Iowa, Iowa City, IA, USA.
• ³ Department of Urology, Moffitt Cancer Center, Tampa, FL, USA.
• ⁴ Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: [email protected].
• ⁵ Department of Urology, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.